nodes	percent_of_prediction	percent_of_DWPC	metapath
Quetiapine—ABCB1—melanoma	0.132	1	CbGaD
Quetiapine—CYP3A4—Temozolomide—melanoma	0.0438	0.189	CbGbCtD
Quetiapine—CYP2D6—Vemurafenib—melanoma	0.0378	0.163	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.0282	0.122	CbGbCtD
Quetiapine—CYP3A7—Docetaxel—melanoma	0.0282	0.122	CbGbCtD
Quetiapine—ABCB1—Dactinomycin—melanoma	0.0266	0.115	CbGbCtD
Quetiapine—CYP3A4—Vemurafenib—melanoma	0.024	0.104	CbGbCtD
Quetiapine—CYP3A5—Docetaxel—melanoma	0.0211	0.0912	CbGbCtD
Quetiapine—HTR1D—meninx—melanoma	0.0186	0.194	CbGeAlD
Quetiapine—DRD5—eyelid—melanoma	0.0169	0.175	CbGeAlD
Quetiapine—ABCB1—Docetaxel—melanoma	0.0138	0.0594	CbGbCtD
Quetiapine—CYP3A4—Docetaxel—melanoma	0.00824	0.0356	CbGbCtD
Quetiapine—CHRM5—skin epidermis—melanoma	0.00473	0.0492	CbGeAlD
Quetiapine—H1F0—hair follicle—melanoma	0.00291	0.0303	CbGeAlD
Quetiapine—HTR2A—hindlimb—melanoma	0.0022	0.0229	CbGeAlD
Quetiapine—HTR1B—blood vessel—melanoma	0.00218	0.0227	CbGeAlD
Quetiapine—HTR1D—blood vessel—melanoma	0.00211	0.022	CbGeAlD
Quetiapine—H1F0—neck—melanoma	0.00195	0.0203	CbGeAlD
Quetiapine—HTR2A—appendage—melanoma	0.00189	0.0196	CbGeAlD
Quetiapine—HTR7—endothelium—melanoma	0.00183	0.019	CbGeAlD
Quetiapine—HTR7—blood vessel—melanoma	0.00168	0.0175	CbGeAlD
Quetiapine—CHRM5—eye—melanoma	0.00168	0.0175	CbGeAlD
Quetiapine—CHRM5—skin of body—melanoma	0.00146	0.0152	CbGeAlD
Quetiapine—H1F0—retina—melanoma	0.00144	0.015	CbGeAlD
Quetiapine—HTR1E—head—melanoma	0.00139	0.0145	CbGeAlD
Quetiapine—H1F0—skin of body—melanoma	0.00126	0.0131	CbGeAlD
Quetiapine—CHRM4—head—melanoma	0.00122	0.0127	CbGeAlD
Quetiapine—HTR7—neck—melanoma	0.0012	0.0125	CbGeAlD
Quetiapine—H1F0—mammalian vulva—melanoma	0.00115	0.012	CbGeAlD
Quetiapine—HTR2A—endothelium—melanoma	0.00114	0.0118	CbGeAlD
Quetiapine—DRD3—head—melanoma	0.00114	0.0118	CbGeAlD
Quetiapine—HTR1D—eye—melanoma	0.00112	0.0117	CbGeAlD
Quetiapine—HTR6—head—melanoma	0.00109	0.0114	CbGeAlD
Quetiapine—DRD5—head—melanoma	0.00106	0.0111	CbGeAlD
Quetiapine—HTR2A—blood vessel—melanoma	0.00105	0.0109	CbGeAlD
Quetiapine—CHRM5—head—melanoma	0.000955	0.00994	CbGeAlD
Quetiapine—ADRA1B—head—melanoma	0.000873	0.00908	CbGeAlD
Quetiapine—ADRA1D—head—melanoma	0.000854	0.00889	CbGeAlD
Quetiapine—DRD2—eye—melanoma	0.000847	0.00881	CbGeAlD
Quetiapine—DRD2—retina—melanoma	0.000839	0.00873	CbGeAlD
Quetiapine—H1F0—head—melanoma	0.000824	0.00858	CbGeAlD
Quetiapine—DRD1—head—melanoma	0.000814	0.00847	CbGeAlD
Quetiapine—HTR3A—head—melanoma	0.000786	0.00818	CbGeAlD
Quetiapine—HTR2A—neck—melanoma	0.000751	0.00781	CbGeAlD
Quetiapine—ABCB1—blood vessel—melanoma	0.000688	0.00716	CbGeAlD
Quetiapine—HRH1—eye—melanoma	0.000669	0.00696	CbGeAlD
Quetiapine—HTR1B—head—melanoma	0.000659	0.00686	CbGeAlD
Quetiapine—CHRM2—head—melanoma	0.000656	0.00682	CbGeAlD
Quetiapine—ADRA2C—mammalian vulva—melanoma	0.000653	0.0068	CbGeAlD
Quetiapine—HTR1D—head—melanoma	0.000638	0.00664	CbGeAlD
Quetiapine—HTR2C—head—melanoma	0.000632	0.00658	CbGeAlD
Quetiapine—CHRM1—head—melanoma	0.000597	0.00621	CbGeAlD
Quetiapine—H1F0—lymph node—melanoma	0.000577	0.006	CbGeAlD
Quetiapine—HTR2A—eye—melanoma	0.000559	0.00581	CbGeAlD
Quetiapine—HTR2A—retina—melanoma	0.000554	0.00576	CbGeAlD
Quetiapine—CHRM3—head—melanoma	0.000534	0.00556	CbGeAlD
Quetiapine—HTR1A—head—melanoma	0.000532	0.00554	CbGeAlD
Quetiapine—HRH1—mammalian vulva—melanoma	0.000531	0.00552	CbGeAlD
Quetiapine—ADRA2A—mammalian vulva—melanoma	0.000521	0.00542	CbGeAlD
Quetiapine—HTR7—head—melanoma	0.000508	0.00529	CbGeAlD
Quetiapine—ADRA1A—head—melanoma	0.00049	0.0051	CbGeAlD
Quetiapine—DRD2—head—melanoma	0.000481	0.005	CbGeAlD
Quetiapine—ADRA2C—head—melanoma	0.000467	0.00486	CbGeAlD
Quetiapine—Angiopathy—Temozolomide—melanoma	0.000391	0.00148	CcSEcCtD
Quetiapine—Mental disorder—Carmustine—melanoma	0.00039	0.00148	CcSEcCtD
Quetiapine—Ataxia—Docetaxel—melanoma	0.000389	0.00148	CcSEcCtD
Quetiapine—Immune system disorder—Temozolomide—melanoma	0.000389	0.00148	CcSEcCtD
Quetiapine—Mediastinal disorder—Temozolomide—melanoma	0.000388	0.00147	CcSEcCtD
Quetiapine—Malnutrition—Carmustine—melanoma	0.000388	0.00147	CcSEcCtD
Quetiapine—Cough—Bleomycin—melanoma	0.000388	0.00147	CcSEcCtD
Quetiapine—Chills—Temozolomide—melanoma	0.000386	0.00147	CcSEcCtD
Quetiapine—Dehydration—Docetaxel—melanoma	0.000385	0.00146	CcSEcCtD
Quetiapine—Ill-defined disorder—Dactinomycin—melanoma	0.000384	0.00146	CcSEcCtD
Quetiapine—Anaemia—Dactinomycin—melanoma	0.000383	0.00145	CcSEcCtD
Quetiapine—Vomiting—Vemurafenib—melanoma	0.000381	0.00144	CcSEcCtD
Quetiapine—HRH1—head—melanoma	0.00038	0.00395	CbGeAlD
Quetiapine—Dry skin—Docetaxel—melanoma	0.000379	0.00144	CcSEcCtD
Quetiapine—Myalgia—Bleomycin—melanoma	0.000378	0.00144	CcSEcCtD
Quetiapine—Chest pain—Bleomycin—melanoma	0.000378	0.00144	CcSEcCtD
Quetiapine—Orthostatic hypotension—Docetaxel—melanoma	0.000378	0.00144	CcSEcCtD
Quetiapine—Abdominal pain upper—Docetaxel—melanoma	0.000378	0.00144	CcSEcCtD
Quetiapine—Rash—Vemurafenib—melanoma	0.000377	0.00143	CcSEcCtD
Quetiapine—Mental disorder—Temozolomide—melanoma	0.000377	0.00143	CcSEcCtD
Quetiapine—Dermatitis—Vemurafenib—melanoma	0.000377	0.00143	CcSEcCtD
Quetiapine—Back pain—Carmustine—melanoma	0.000375	0.00142	CcSEcCtD
Quetiapine—Headache—Vemurafenib—melanoma	0.000375	0.00142	CcSEcCtD
Quetiapine—Malnutrition—Temozolomide—melanoma	0.000375	0.00142	CcSEcCtD
Quetiapine—Breast disorder—Docetaxel—melanoma	0.000374	0.00142	CcSEcCtD
Quetiapine—Discomfort—Bleomycin—melanoma	0.000374	0.00142	CcSEcCtD
Quetiapine—Malaise—Dactinomycin—melanoma	0.000374	0.00142	CcSEcCtD
Quetiapine—ADRA2A—head—melanoma	0.000373	0.00388	CbGeAlD
Quetiapine—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000373	0.00141	CcSEcCtD
Quetiapine—Cramp muscle—Docetaxel—melanoma	0.000373	0.00141	CcSEcCtD
Quetiapine—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000373	0.00141	CcSEcCtD
Quetiapine—Leukopenia—Dactinomycin—melanoma	0.000371	0.00141	CcSEcCtD
Quetiapine—Nasopharyngitis—Docetaxel—melanoma	0.00037	0.0014	CcSEcCtD
Quetiapine—Dysgeusia—Temozolomide—melanoma	0.000367	0.00139	CcSEcCtD
Quetiapine—Confusional state—Bleomycin—melanoma	0.000366	0.00139	CcSEcCtD
Quetiapine—Vision blurred—Carmustine—melanoma	0.000365	0.00139	CcSEcCtD
Quetiapine—Alanine aminotransferase increased—Docetaxel—melanoma	0.000365	0.00139	CcSEcCtD
Quetiapine—Tremor—Carmustine—melanoma	0.000363	0.00138	CcSEcCtD
Quetiapine—ABCB1—retina—melanoma	0.000363	0.00378	CbGeAlD
Quetiapine—Anaphylactic shock—Bleomycin—melanoma	0.000363	0.00138	CcSEcCtD
Quetiapine—Back pain—Temozolomide—melanoma	0.000363	0.00138	CcSEcCtD
Quetiapine—Infection—Bleomycin—melanoma	0.00036	0.00137	CcSEcCtD
Quetiapine—Anaemia—Carmustine—melanoma	0.000358	0.00136	CcSEcCtD
Quetiapine—Dysphagia—Docetaxel—melanoma	0.000358	0.00136	CcSEcCtD
Quetiapine—Agitation—Carmustine—melanoma	0.000356	0.00135	CcSEcCtD
Quetiapine—Nausea—Vemurafenib—melanoma	0.000355	0.00135	CcSEcCtD
Quetiapine—Thrombocytopenia—Bleomycin—melanoma	0.000355	0.00135	CcSEcCtD
Quetiapine—Vision blurred—Temozolomide—melanoma	0.000353	0.00134	CcSEcCtD
Quetiapine—Myalgia—Dactinomycin—melanoma	0.000353	0.00134	CcSEcCtD
Quetiapine—Tremor—Temozolomide—melanoma	0.000351	0.00133	CcSEcCtD
Quetiapine—Discomfort—Dactinomycin—melanoma	0.000349	0.00132	CcSEcCtD
Quetiapine—Angina pectoris—Docetaxel—melanoma	0.000348	0.00132	CcSEcCtD
Quetiapine—Ill-defined disorder—Temozolomide—melanoma	0.000348	0.00132	CcSEcCtD
Quetiapine—Leukopenia—Carmustine—melanoma	0.000347	0.00132	CcSEcCtD
Quetiapine—Anaemia—Temozolomide—melanoma	0.000346	0.00132	CcSEcCtD
Quetiapine—Anorexia—Bleomycin—melanoma	0.000346	0.00131	CcSEcCtD
Quetiapine—Agitation—Temozolomide—melanoma	0.000344	0.00131	CcSEcCtD
Quetiapine—Angioedema—Temozolomide—melanoma	0.000342	0.0013	CcSEcCtD
Quetiapine—Hypotension—Bleomycin—melanoma	0.000339	0.00129	CcSEcCtD
Quetiapine—Malaise—Temozolomide—melanoma	0.000338	0.00128	CcSEcCtD
Quetiapine—Vertigo—Temozolomide—melanoma	0.000337	0.00128	CcSEcCtD
Quetiapine—Convulsion—Carmustine—melanoma	0.000336	0.00128	CcSEcCtD
Quetiapine—Infection—Dactinomycin—melanoma	0.000336	0.00128	CcSEcCtD
Quetiapine—Leukopenia—Temozolomide—melanoma	0.000335	0.00127	CcSEcCtD
Quetiapine—Hypertension—Carmustine—melanoma	0.000335	0.00127	CcSEcCtD
Quetiapine—Neutropenia—Docetaxel—melanoma	0.000334	0.00127	CcSEcCtD
Quetiapine—Palpitations—Temozolomide—melanoma	0.000331	0.00126	CcSEcCtD
Quetiapine—Thrombocytopenia—Dactinomycin—melanoma	0.000331	0.00126	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Bleomycin—melanoma	0.00033	0.00125	CcSEcCtD
Quetiapine—Myalgia—Carmustine—melanoma	0.00033	0.00125	CcSEcCtD
Quetiapine—Chest pain—Carmustine—melanoma	0.00033	0.00125	CcSEcCtD
Quetiapine—Anxiety—Carmustine—melanoma	0.000329	0.00125	CcSEcCtD
Quetiapine—ADRA2C—lymph node—melanoma	0.000327	0.00341	CbGeAlD
Quetiapine—Cough—Temozolomide—melanoma	0.000327	0.00124	CcSEcCtD
Quetiapine—Paraesthesia—Bleomycin—melanoma	0.000326	0.00124	CcSEcCtD
Quetiapine—Weight increased—Docetaxel—melanoma	0.000326	0.00124	CcSEcCtD
Quetiapine—Convulsion—Temozolomide—melanoma	0.000325	0.00123	CcSEcCtD
Quetiapine—Weight decreased—Docetaxel—melanoma	0.000324	0.00123	CcSEcCtD
Quetiapine—Hypertension—Temozolomide—melanoma	0.000324	0.00123	CcSEcCtD
Quetiapine—Dyspnoea—Bleomycin—melanoma	0.000323	0.00123	CcSEcCtD
Quetiapine—Anorexia—Dactinomycin—melanoma	0.000322	0.00122	CcSEcCtD
Quetiapine—Pneumonia—Docetaxel—melanoma	0.000321	0.00122	CcSEcCtD
Quetiapine—Confusional state—Carmustine—melanoma	0.000319	0.00121	CcSEcCtD
Quetiapine—Myalgia—Temozolomide—melanoma	0.000319	0.00121	CcSEcCtD
Quetiapine—Arthralgia—Temozolomide—melanoma	0.000319	0.00121	CcSEcCtD
Quetiapine—Infestation NOS—Docetaxel—melanoma	0.000319	0.00121	CcSEcCtD
Quetiapine—Infestation—Docetaxel—melanoma	0.000319	0.00121	CcSEcCtD
Quetiapine—Anxiety—Temozolomide—melanoma	0.000318	0.00121	CcSEcCtD
Quetiapine—HTR2A—head—melanoma	0.000317	0.0033	CbGeAlD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000317	0.0012	CcSEcCtD
Quetiapine—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000316	0.0012	CcSEcCtD
Quetiapine—Discomfort—Temozolomide—melanoma	0.000315	0.0012	CcSEcCtD
Quetiapine—Decreased appetite—Bleomycin—melanoma	0.000315	0.0012	CcSEcCtD
Quetiapine—Infection—Carmustine—melanoma	0.000314	0.00119	CcSEcCtD
Quetiapine—Dry mouth—Temozolomide—melanoma	0.000312	0.00118	CcSEcCtD
Quetiapine—Stomatitis—Docetaxel—melanoma	0.000311	0.00118	CcSEcCtD
Quetiapine—Jaundice—Docetaxel—melanoma	0.000311	0.00118	CcSEcCtD
Quetiapine—Pain—Bleomycin—melanoma	0.00031	0.00118	CcSEcCtD
Quetiapine—Conjunctivitis—Docetaxel—melanoma	0.00031	0.00118	CcSEcCtD
Quetiapine—Thrombocytopenia—Carmustine—melanoma	0.00031	0.00118	CcSEcCtD
Quetiapine—Tachycardia—Carmustine—melanoma	0.000309	0.00117	CcSEcCtD
Quetiapine—Confusional state—Temozolomide—melanoma	0.000308	0.00117	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000308	0.00117	CcSEcCtD
Quetiapine—Anaphylactic shock—Temozolomide—melanoma	0.000306	0.00116	CcSEcCtD
Quetiapine—Infection—Temozolomide—melanoma	0.000304	0.00115	CcSEcCtD
Quetiapine—Anorexia—Carmustine—melanoma	0.000302	0.00115	CcSEcCtD
Quetiapine—Hepatobiliary disease—Docetaxel—melanoma	0.000302	0.00115	CcSEcCtD
Quetiapine—Epistaxis—Docetaxel—melanoma	0.000301	0.00114	CcSEcCtD
Quetiapine—Nervous system disorder—Temozolomide—melanoma	0.0003	0.00114	CcSEcCtD
Quetiapine—Thrombocytopenia—Temozolomide—melanoma	0.000299	0.00114	CcSEcCtD
Quetiapine—Feeling abnormal—Bleomycin—melanoma	0.000299	0.00113	CcSEcCtD
Quetiapine—Agranulocytosis—Docetaxel—melanoma	0.000298	0.00113	CcSEcCtD
Quetiapine—Skin disorder—Temozolomide—melanoma	0.000297	0.00113	CcSEcCtD
Quetiapine—Hypotension—Carmustine—melanoma	0.000296	0.00112	CcSEcCtD
Quetiapine—Hyperhidrosis—Temozolomide—melanoma	0.000296	0.00112	CcSEcCtD
Quetiapine—Decreased appetite—Dactinomycin—melanoma	0.000294	0.00112	CcSEcCtD
Quetiapine—Fatigue—Dactinomycin—melanoma	0.000292	0.00111	CcSEcCtD
Quetiapine—Anorexia—Temozolomide—melanoma	0.000292	0.00111	CcSEcCtD
Quetiapine—ABCB1—mammalian vulva—melanoma	0.00029	0.00302	CbGeAlD
Quetiapine—Pain—Dactinomycin—melanoma	0.000289	0.0011	CcSEcCtD
Quetiapine—CYP2D6—head—melanoma	0.000289	0.00301	CbGeAlD
Quetiapine—Musculoskeletal discomfort—Carmustine—melanoma	0.000288	0.00109	CcSEcCtD
Quetiapine—Haemoglobin—Docetaxel—melanoma	0.000288	0.00109	CcSEcCtD
Quetiapine—Rhinitis—Docetaxel—melanoma	0.000287	0.00109	CcSEcCtD
Quetiapine—Body temperature increased—Bleomycin—melanoma	0.000287	0.00109	CcSEcCtD
Quetiapine—Hepatitis—Docetaxel—melanoma	0.000286	0.00109	CcSEcCtD
Quetiapine—Haemorrhage—Docetaxel—melanoma	0.000286	0.00109	CcSEcCtD
Quetiapine—Insomnia—Carmustine—melanoma	0.000286	0.00109	CcSEcCtD
Quetiapine—Hypoaesthesia—Docetaxel—melanoma	0.000285	0.00108	CcSEcCtD
Quetiapine—Paraesthesia—Carmustine—melanoma	0.000284	0.00108	CcSEcCtD
Quetiapine—Pharyngitis—Docetaxel—melanoma	0.000284	0.00108	CcSEcCtD
Quetiapine—Urinary tract disorder—Docetaxel—melanoma	0.000283	0.00107	CcSEcCtD
Quetiapine—Dyspnoea—Carmustine—melanoma	0.000282	0.00107	CcSEcCtD
Quetiapine—Oedema peripheral—Docetaxel—melanoma	0.000282	0.00107	CcSEcCtD
Quetiapine—Somnolence—Carmustine—melanoma	0.000281	0.00107	CcSEcCtD
Quetiapine—Connective tissue disorder—Docetaxel—melanoma	0.000281	0.00107	CcSEcCtD
Quetiapine—Urethral disorder—Docetaxel—melanoma	0.000281	0.00107	CcSEcCtD
Quetiapine—Feeling abnormal—Dactinomycin—melanoma	0.000279	0.00106	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Temozolomide—melanoma	0.000279	0.00106	CcSEcCtD
Quetiapine—Insomnia—Temozolomide—melanoma	0.000277	0.00105	CcSEcCtD
Quetiapine—Gastrointestinal pain—Dactinomycin—melanoma	0.000277	0.00105	CcSEcCtD
Quetiapine—Visual impairment—Docetaxel—melanoma	0.000276	0.00105	CcSEcCtD
Quetiapine—Decreased appetite—Carmustine—melanoma	0.000275	0.00104	CcSEcCtD
Quetiapine—Paraesthesia—Temozolomide—melanoma	0.000275	0.00104	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Carmustine—melanoma	0.000273	0.00104	CcSEcCtD
Quetiapine—Dyspnoea—Temozolomide—melanoma	0.000273	0.00104	CcSEcCtD
Quetiapine—Somnolence—Temozolomide—melanoma	0.000272	0.00103	CcSEcCtD
Quetiapine—Erythema multiforme—Docetaxel—melanoma	0.000271	0.00103	CcSEcCtD
Quetiapine—Pain—Carmustine—melanoma	0.000271	0.00103	CcSEcCtD
Quetiapine—Constipation—Carmustine—melanoma	0.000271	0.00103	CcSEcCtD
Quetiapine—Dyspepsia—Temozolomide—melanoma	0.000269	0.00102	CcSEcCtD
Quetiapine—Eye disorder—Docetaxel—melanoma	0.000268	0.00102	CcSEcCtD
Quetiapine—Body temperature increased—Dactinomycin—melanoma	0.000267	0.00101	CcSEcCtD
Quetiapine—Abdominal pain—Dactinomycin—melanoma	0.000267	0.00101	CcSEcCtD
Quetiapine—Hypersensitivity—Bleomycin—melanoma	0.000267	0.00101	CcSEcCtD
Quetiapine—Decreased appetite—Temozolomide—melanoma	0.000266	0.00101	CcSEcCtD
Quetiapine—HRH1—lymph node—melanoma	0.000266	0.00277	CbGeAlD
Quetiapine—Cardiac disorder—Docetaxel—melanoma	0.000266	0.00101	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Temozolomide—melanoma	0.000264	0.001	CcSEcCtD
Quetiapine—Fatigue—Temozolomide—melanoma	0.000264	0.001	CcSEcCtD
Quetiapine—Constipation—Temozolomide—melanoma	0.000262	0.000993	CcSEcCtD
Quetiapine—Pain—Temozolomide—melanoma	0.000262	0.000993	CcSEcCtD
Quetiapine—ADRA2A—lymph node—melanoma	0.000261	0.00272	CbGeAlD
Quetiapine—Feeling abnormal—Carmustine—melanoma	0.000261	0.00099	CcSEcCtD
Quetiapine—Asthenia—Bleomycin—melanoma	0.00026	0.000988	CcSEcCtD
Quetiapine—Angiopathy—Docetaxel—melanoma	0.00026	0.000986	CcSEcCtD
Quetiapine—Gastrointestinal pain—Carmustine—melanoma	0.000259	0.000983	CcSEcCtD
Quetiapine—Immune system disorder—Docetaxel—melanoma	0.000259	0.000982	CcSEcCtD
Quetiapine—Mediastinal disorder—Docetaxel—melanoma	0.000258	0.00098	CcSEcCtD
Quetiapine—Chills—Docetaxel—melanoma	0.000257	0.000975	CcSEcCtD
Quetiapine—Pruritus—Bleomycin—melanoma	0.000257	0.000974	CcSEcCtD
Quetiapine—Feeling abnormal—Temozolomide—melanoma	0.000252	0.000957	CcSEcCtD
Quetiapine—Mental disorder—Docetaxel—melanoma	0.000251	0.000952	CcSEcCtD
Quetiapine—Body temperature increased—Carmustine—melanoma	0.00025	0.00095	CcSEcCtD
Quetiapine—Abdominal pain—Carmustine—melanoma	0.00025	0.00095	CcSEcCtD
Quetiapine—Gastrointestinal pain—Temozolomide—melanoma	0.00025	0.00095	CcSEcCtD
Quetiapine—Malnutrition—Docetaxel—melanoma	0.000249	0.000946	CcSEcCtD
Quetiapine—Hypersensitivity—Dactinomycin—melanoma	0.000249	0.000946	CcSEcCtD
Quetiapine—Flupentixol—ABCB1—melanoma	0.000244	0.149	CrCbGaD
Quetiapine—Dysgeusia—Docetaxel—melanoma	0.000244	0.000927	CcSEcCtD
Quetiapine—Asthenia—Dactinomycin—melanoma	0.000243	0.000921	CcSEcCtD
Quetiapine—Body temperature increased—Temozolomide—melanoma	0.000242	0.000918	CcSEcCtD
Quetiapine—Abdominal pain—Temozolomide—melanoma	0.000242	0.000918	CcSEcCtD
Quetiapine—Back pain—Docetaxel—melanoma	0.000241	0.000915	CcSEcCtD
Quetiapine—Muscle spasms—Docetaxel—melanoma	0.00024	0.00091	CcSEcCtD
Quetiapine—Clozapine—CYP1B1—melanoma	0.000238	0.145	CrCbGaD
Quetiapine—Hypersensitivity—Carmustine—melanoma	0.000233	0.000885	CcSEcCtD
Quetiapine—Diarrhoea—Dactinomycin—melanoma	0.000231	0.000878	CcSEcCtD
Quetiapine—Vomiting—Bleomycin—melanoma	0.000231	0.000875	CcSEcCtD
Quetiapine—Anaemia—Docetaxel—melanoma	0.00023	0.000875	CcSEcCtD
Quetiapine—Rash—Bleomycin—melanoma	0.000229	0.000868	CcSEcCtD
Quetiapine—Dermatitis—Bleomycin—melanoma	0.000228	0.000867	CcSEcCtD
Quetiapine—Asthenia—Carmustine—melanoma	0.000227	0.000862	CcSEcCtD
Quetiapine—Hypersensitivity—Temozolomide—melanoma	0.000225	0.000856	CcSEcCtD
Quetiapine—Syncope—Docetaxel—melanoma	0.000224	0.000849	CcSEcCtD
Quetiapine—Leukopenia—Docetaxel—melanoma	0.000223	0.000847	CcSEcCtD
Quetiapine—Palpitations—Docetaxel—melanoma	0.00022	0.000836	CcSEcCtD
Quetiapine—Asthenia—Temozolomide—melanoma	0.000219	0.000833	CcSEcCtD
Quetiapine—Loss of consciousness—Docetaxel—melanoma	0.000219	0.000832	CcSEcCtD
Quetiapine—Cough—Docetaxel—melanoma	0.000217	0.000826	CcSEcCtD
Quetiapine—Diarrhoea—Carmustine—melanoma	0.000217	0.000822	CcSEcCtD
Quetiapine—Pruritus—Temozolomide—melanoma	0.000216	0.000822	CcSEcCtD
Quetiapine—Convulsion—Docetaxel—melanoma	0.000216	0.00082	CcSEcCtD
Quetiapine—Nausea—Bleomycin—melanoma	0.000215	0.000818	CcSEcCtD
Quetiapine—Hypertension—Docetaxel—melanoma	0.000215	0.000817	CcSEcCtD
Quetiapine—Vomiting—Dactinomycin—melanoma	0.000215	0.000816	CcSEcCtD
Quetiapine—Rash—Dactinomycin—melanoma	0.000213	0.00081	CcSEcCtD
Quetiapine—Chest pain—Docetaxel—melanoma	0.000212	0.000806	CcSEcCtD
Quetiapine—Arthralgia—Docetaxel—melanoma	0.000212	0.000806	CcSEcCtD
Quetiapine—Myalgia—Docetaxel—melanoma	0.000212	0.000806	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000211	0.0008	CcSEcCtD
Quetiapine—Dizziness—Carmustine—melanoma	0.000209	0.000795	CcSEcCtD
Quetiapine—Diarrhoea—Temozolomide—melanoma	0.000209	0.000795	CcSEcCtD
Quetiapine—ABCB1—head—melanoma	0.000208	0.00216	CbGeAlD
Quetiapine—Dry mouth—Docetaxel—melanoma	0.000208	0.000788	CcSEcCtD
Quetiapine—Confusional state—Docetaxel—melanoma	0.000205	0.000779	CcSEcCtD
Quetiapine—Anaphylactic shock—Docetaxel—melanoma	0.000203	0.000772	CcSEcCtD
Quetiapine—Dizziness—Temozolomide—melanoma	0.000202	0.000768	CcSEcCtD
Quetiapine—Infection—Docetaxel—melanoma	0.000202	0.000767	CcSEcCtD
Quetiapine—Vomiting—Carmustine—melanoma	0.000201	0.000764	CcSEcCtD
Quetiapine—Nausea—Dactinomycin—melanoma	0.000201	0.000763	CcSEcCtD
Quetiapine—Shock—Docetaxel—melanoma	0.0002	0.00076	CcSEcCtD
Quetiapine—Rash—Carmustine—melanoma	0.0002	0.000758	CcSEcCtD
Quetiapine—Nervous system disorder—Docetaxel—melanoma	0.000199	0.000757	CcSEcCtD
Quetiapine—Dermatitis—Carmustine—melanoma	0.000199	0.000757	CcSEcCtD
Quetiapine—Thrombocytopenia—Docetaxel—melanoma	0.000199	0.000756	CcSEcCtD
Quetiapine—Tachycardia—Docetaxel—melanoma	0.000199	0.000754	CcSEcCtD
Quetiapine—Headache—Carmustine—melanoma	0.000198	0.000753	CcSEcCtD
Quetiapine—Skin disorder—Docetaxel—melanoma	0.000198	0.00075	CcSEcCtD
Quetiapine—Vomiting—Temozolomide—melanoma	0.000194	0.000738	CcSEcCtD
Quetiapine—Anorexia—Docetaxel—melanoma	0.000194	0.000736	CcSEcCtD
Quetiapine—Rash—Temozolomide—melanoma	0.000193	0.000732	CcSEcCtD
Quetiapine—Dermatitis—Temozolomide—melanoma	0.000193	0.000731	CcSEcCtD
Quetiapine—Headache—Temozolomide—melanoma	0.000192	0.000727	CcSEcCtD
Quetiapine—Hypotension—Docetaxel—melanoma	0.00019	0.000722	CcSEcCtD
Quetiapine—Nausea—Carmustine—melanoma	0.000188	0.000714	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Docetaxel—melanoma	0.000185	0.000704	CcSEcCtD
Quetiapine—Insomnia—Docetaxel—melanoma	0.000184	0.000698	CcSEcCtD
Quetiapine—Paraesthesia—Docetaxel—melanoma	0.000183	0.000693	CcSEcCtD
Quetiapine—Nausea—Temozolomide—melanoma	0.000182	0.00069	CcSEcCtD
Quetiapine—Dyspnoea—Docetaxel—melanoma	0.000181	0.000688	CcSEcCtD
Quetiapine—Somnolence—Docetaxel—melanoma	0.000181	0.000687	CcSEcCtD
Quetiapine—Dyspepsia—Docetaxel—melanoma	0.000179	0.00068	CcSEcCtD
Quetiapine—Decreased appetite—Docetaxel—melanoma	0.000177	0.000671	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Docetaxel—melanoma	0.000176	0.000667	CcSEcCtD
Quetiapine—Fatigue—Docetaxel—melanoma	0.000175	0.000666	CcSEcCtD
Quetiapine—Constipation—Docetaxel—melanoma	0.000174	0.00066	CcSEcCtD
Quetiapine—Pain—Docetaxel—melanoma	0.000174	0.00066	CcSEcCtD
Quetiapine—Feeling abnormal—Docetaxel—melanoma	0.000168	0.000636	CcSEcCtD
Quetiapine—Gastrointestinal pain—Docetaxel—melanoma	0.000166	0.000631	CcSEcCtD
Quetiapine—Body temperature increased—Docetaxel—melanoma	0.000161	0.00061	CcSEcCtD
Quetiapine—Abdominal pain—Docetaxel—melanoma	0.000161	0.00061	CcSEcCtD
Quetiapine—Hypersensitivity—Docetaxel—melanoma	0.00015	0.000569	CcSEcCtD
Quetiapine—Asthenia—Docetaxel—melanoma	0.000146	0.000554	CcSEcCtD
Quetiapine—ABCB1—lymph node—melanoma	0.000145	0.00151	CbGeAlD
Quetiapine—Pruritus—Docetaxel—melanoma	0.000144	0.000546	CcSEcCtD
Quetiapine—Diarrhoea—Docetaxel—melanoma	0.000139	0.000528	CcSEcCtD
Quetiapine—Olanzapine—ALB—melanoma	0.000137	0.0836	CrCbGaD
Quetiapine—Nefazodone—ABCB1—melanoma	0.000136	0.0833	CrCbGaD
Quetiapine—Dizziness—Docetaxel—melanoma	0.000135	0.000511	CcSEcCtD
Quetiapine—Olanzapine—ABCB1—melanoma	0.000131	0.0798	CrCbGaD
Quetiapine—Vomiting—Docetaxel—melanoma	0.000129	0.000491	CcSEcCtD
Quetiapine—Rash—Docetaxel—melanoma	0.000128	0.000487	CcSEcCtD
Quetiapine—Dermatitis—Docetaxel—melanoma	0.000128	0.000486	CcSEcCtD
Quetiapine—Headache—Docetaxel—melanoma	0.000127	0.000484	CcSEcCtD
Quetiapine—Trazodone—ABCB1—melanoma	0.000126	0.0771	CrCbGaD
Quetiapine—Thioproperazine—ALB—melanoma	0.000126	0.0769	CrCbGaD
Quetiapine—Thiothixene—ALB—melanoma	0.000124	0.0757	CrCbGaD
Quetiapine—Pipotiazine—ALB—melanoma	0.000124	0.0757	CrCbGaD
Quetiapine—Nausea—Docetaxel—melanoma	0.000121	0.000459	CcSEcCtD
Quetiapine—Fluphenazine—ABCB1—melanoma	0.000102	0.0624	CrCbGaD
Quetiapine—Trifluoperazine—ABCB1—melanoma	8.17e-05	0.0499	CrCbGaD
Quetiapine—Clozapine—ABCB1—melanoma	6.82e-05	0.0416	CrCbGaD
Quetiapine—ABCB1—Metabolism—ALB—melanoma	3.49e-06	1.27e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—STAT3—melanoma	3.49e-06	1.27e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—MMP9—melanoma	3.48e-06	1.26e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CDKN1A—melanoma	3.48e-06	1.26e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—MAPK3—melanoma	3.48e-06	1.26e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—NRAS—melanoma	3.48e-06	1.26e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—PTEN—melanoma	3.47e-06	1.26e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CDKN1A—melanoma	3.47e-06	1.26e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—PTEN—melanoma	3.46e-06	1.26e-05	CbGpPWpGaD
Quetiapine—ADRA2A—GPCR downstream signaling—AKT1—melanoma	3.46e-06	1.26e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—NFKB1—melanoma	3.45e-06	1.25e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—IL6—melanoma	3.45e-06	1.25e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—HRAS—melanoma	3.45e-06	1.25e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—IL6—melanoma	3.45e-06	1.25e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—AKT1—melanoma	3.45e-06	1.25e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—MAPK1—melanoma	3.45e-06	1.25e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—EGFR—melanoma	3.45e-06	1.25e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—NFKB1—melanoma	3.45e-06	1.25e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—AKT1—melanoma	3.44e-06	1.25e-05	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—PIK3CA—melanoma	3.44e-06	1.25e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—ABCB1—melanoma	3.43e-06	1.25e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—AKT1—melanoma	3.43e-06	1.25e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—IL6—melanoma	3.43e-06	1.25e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CASP3—melanoma	3.42e-06	1.24e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—AKT1—melanoma	3.42e-06	1.24e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—IL2—melanoma	3.42e-06	1.24e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—TP53—melanoma	3.41e-06	1.24e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—HRAS—melanoma	3.4e-06	1.24e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—IL6—melanoma	3.4e-06	1.24e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—MYC—melanoma	3.4e-06	1.24e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—AKT1—melanoma	3.39e-06	1.23e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—MAPK3—melanoma	3.38e-06	1.23e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—MYC—melanoma	3.38e-06	1.23e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—AKT1—melanoma	3.38e-06	1.23e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—PIK3CA—melanoma	3.36e-06	1.22e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—IL6—melanoma	3.36e-06	1.22e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—PIK3CA—melanoma	3.34e-06	1.21e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CCND1—melanoma	3.33e-06	1.21e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—MAPK3—melanoma	3.33e-06	1.21e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PIK3CD—melanoma	3.33e-06	1.21e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—MAPK1—melanoma	3.33e-06	1.21e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—EGFR—melanoma	3.33e-06	1.21e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—PIK3CA—melanoma	3.31e-06	1.2e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—PIK3CA—melanoma	3.31e-06	1.2e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—MAPK1—melanoma	3.31e-06	1.2e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—EGFR—melanoma	3.31e-06	1.2e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—IL6—melanoma	3.3e-06	1.2e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CTNNB1—melanoma	3.3e-06	1.2e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—MYC—melanoma	3.29e-06	1.2e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—ALB—melanoma	3.29e-06	1.19e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—HRAS—melanoma	3.26e-06	1.18e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—IL6—melanoma	3.26e-06	1.18e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—KRAS—melanoma	3.26e-06	1.18e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—TP53—melanoma	3.25e-06	1.18e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—VEGFA—melanoma	3.25e-06	1.18e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—MYC—melanoma	3.24e-06	1.18e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MMP9—melanoma	3.24e-06	1.18e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CDKN1A—melanoma	3.22e-06	1.17e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—MAPK1—melanoma	3.22e-06	1.17e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—EGFR—melanoma	3.22e-06	1.17e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—PTEN—melanoma	3.22e-06	1.17e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—STAT3—melanoma	3.21e-06	1.17e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—NRAS—melanoma	3.21e-06	1.16e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—TP53—melanoma	3.21e-06	1.16e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—TP53—melanoma	3.21e-06	1.16e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—NFKB1—melanoma	3.2e-06	1.16e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—VEGFA—melanoma	3.19e-06	1.16e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—VEGFA—melanoma	3.19e-06	1.16e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—AKT1—melanoma	3.19e-06	1.16e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—AKT1—melanoma	3.18e-06	1.16e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—VEGFA—melanoma	3.18e-06	1.15e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—MAPK1—melanoma	3.17e-06	1.15e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—EGFR—melanoma	3.17e-06	1.15e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—VEGFA—melanoma	3.17e-06	1.15e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—AKT1—melanoma	3.16e-06	1.15e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—STAT3—melanoma	3.16e-06	1.15e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PRKCA—melanoma	3.16e-06	1.15e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—STAT3—melanoma	3.16e-06	1.15e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—NRAS—melanoma	3.15e-06	1.15e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PIK3CB—melanoma	3.15e-06	1.15e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—NRAS—melanoma	3.15e-06	1.14e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—STAT3—melanoma	3.15e-06	1.14e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—KRAS—melanoma	3.14e-06	1.14e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—AKT1—melanoma	3.14e-06	1.14e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—NRAS—melanoma	3.14e-06	1.14e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—VEGFA—melanoma	3.14e-06	1.14e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—STAT3—melanoma	3.14e-06	1.14e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—ERCC2—melanoma	3.13e-06	1.14e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—NRAS—melanoma	3.13e-06	1.14e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—VEGFA—melanoma	3.13e-06	1.14e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—KRAS—melanoma	3.13e-06	1.14e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PTGS2—melanoma	3.13e-06	1.14e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—IL6—melanoma	3.12e-06	1.13e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—HRAS—melanoma	3.11e-06	1.13e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—STAT3—melanoma	3.1e-06	1.13e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—NRAS—melanoma	3.1e-06	1.13e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—AKT1—melanoma	3.1e-06	1.12e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—STAT3—melanoma	3.1e-06	1.12e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—NRAS—melanoma	3.09e-06	1.12e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PIK3CB—melanoma	3.08e-06	1.12e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—MAPK3—melanoma	3.07e-06	1.12e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—HRAS—melanoma	3.07e-06	1.11e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—HRAS—melanoma	3.07e-06	1.11e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PTGS2—melanoma	3.05e-06	1.11e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—AKT1—melanoma	3.05e-06	1.11e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—KRAS—melanoma	3.04e-06	1.1e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—MAPK3—melanoma	3.02e-06	1.1e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—MAPK3—melanoma	3.01e-06	1.1e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—AKT1—melanoma	3.01e-06	1.09e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—MAPK3—melanoma	3e-06	1.09e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—MAPK3—melanoma	3e-06	1.09e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—KRAS—melanoma	2.99e-06	1.09e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—PIK3CA—melanoma	2.99e-06	1.09e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—MYC—melanoma	2.99e-06	1.08e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—IL6—melanoma	2.97e-06	1.08e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—MAPK3—melanoma	2.97e-06	1.08e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—MAPK3—melanoma	2.96e-06	1.07e-05	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—PIK3CA—melanoma	2.96e-06	1.07e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—MYC—melanoma	2.94e-06	1.07e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—IL6—melanoma	2.93e-06	1.07e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—IL6—melanoma	2.93e-06	1.07e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—MYC—melanoma	2.93e-06	1.07e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—MYC—melanoma	2.92e-06	1.06e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—MAPK1—melanoma	2.92e-06	1.06e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—EGFR—melanoma	2.92e-06	1.06e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—MYC—melanoma	2.91e-06	1.06e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—VEGFA—melanoma	2.91e-06	1.06e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PIK3CB—melanoma	2.9e-06	1.05e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—TP53—melanoma	2.89e-06	1.05e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—PIK3CA—melanoma	2.89e-06	1.05e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—MYC—melanoma	2.89e-06	1.05e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—AKT1—melanoma	2.88e-06	1.05e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—MYC—melanoma	2.88e-06	1.05e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—STAT3—melanoma	2.88e-06	1.04e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—MAPK1—melanoma	2.87e-06	1.04e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PTGS2—melanoma	2.87e-06	1.04e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—EGFR—melanoma	2.87e-06	1.04e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—PIK3CA—melanoma	2.87e-06	1.04e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—NRAS—melanoma	2.87e-06	1.04e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—MAPK1—melanoma	2.87e-06	1.04e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—EGFR—melanoma	2.87e-06	1.04e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—MAPK1—melanoma	2.86e-06	1.04e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—EGFR—melanoma	2.86e-06	1.04e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—MAPK1—melanoma	2.85e-06	1.04e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—EGFR—melanoma	2.85e-06	1.04e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—MAPK1—melanoma	2.82e-06	1.03e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—EGFR—melanoma	2.82e-06	1.03e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—MAPK1—melanoma	2.81e-06	1.02e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—EGFR—melanoma	2.81e-06	1.02e-05	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—AKT1—melanoma	2.81e-06	1.02e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—PIK3CA—melanoma	2.79e-06	1.01e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—TP53—melanoma	2.79e-06	1.01e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—TP53—melanoma	2.78e-06	1.01e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—HRAS—melanoma	2.77e-06	1.01e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—KRAS—melanoma	2.76e-06	1e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—PIK3CA—melanoma	2.75e-06	9.99e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MAPK3—melanoma	2.75e-06	9.98e-06	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—AKT1—melanoma	2.74e-06	9.96e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—AKT1—melanoma	2.73e-06	9.91e-06	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PTEN—melanoma	2.73e-06	9.9e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—KRAS—melanoma	2.72e-06	9.86e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—PIK3CA—melanoma	2.71e-06	9.86e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—KRAS—melanoma	2.71e-06	9.84e-06	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—AKT1—melanoma	2.71e-06	9.83e-06	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—AKT1—melanoma	2.71e-06	9.83e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—TP53—melanoma	2.7e-06	9.82e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—KRAS—melanoma	2.7e-06	9.81e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—KRAS—melanoma	2.69e-06	9.78e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MYC—melanoma	2.67e-06	9.71e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—HRAS—melanoma	2.67e-06	9.7e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—KRAS—melanoma	2.67e-06	9.68e-06	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PTEN—melanoma	2.66e-06	9.66e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—TP53—melanoma	2.66e-06	9.66e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—KRAS—melanoma	2.66e-06	9.66e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—HRAS—melanoma	2.66e-06	9.65e-06	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—IL6—melanoma	2.65e-06	9.62e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MAPK1—melanoma	2.62e-06	9.5e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—EGFR—melanoma	2.61e-06	9.5e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—HRAS—melanoma	2.58e-06	9.39e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—IL6—melanoma	2.56e-06	9.29e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—HRAS—melanoma	2.54e-06	9.24e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—IL6—melanoma	2.54e-06	9.24e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—PIK3CA—melanoma	2.54e-06	9.21e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PTEN—melanoma	2.51e-06	9.11e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—PIK3CA—melanoma	2.49e-06	9.06e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—PIK3CA—melanoma	2.49e-06	9.04e-06	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—PIK3CA—melanoma	2.49e-06	9.03e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—PIK3CA—melanoma	2.48e-06	9.01e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PIK3CG—melanoma	2.48e-06	8.99e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—IL6—melanoma	2.47e-06	8.99e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—PIK3CA—melanoma	2.47e-06	8.98e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—KRAS—melanoma	2.47e-06	8.97e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—TP53—melanoma	2.45e-06	8.91e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—PIK3CA—melanoma	2.45e-06	8.9e-06	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—AKT1—melanoma	2.44e-06	8.88e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—PIK3CA—melanoma	2.44e-06	8.87e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—IL6—melanoma	2.43e-06	8.84e-06	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—AKT1—melanoma	2.42e-06	8.78e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—TP53—melanoma	2.41e-06	8.77e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—TP53—melanoma	2.41e-06	8.75e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—TP53—melanoma	2.4e-06	8.72e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—TP53—melanoma	2.39e-06	8.69e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PPARG—melanoma	2.39e-06	8.68e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—TP53—melanoma	2.37e-06	8.61e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—TP53—melanoma	2.36e-06	8.58e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—AKT1—melanoma	2.36e-06	8.57e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—AKT1—melanoma	2.35e-06	8.52e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—HRAS—melanoma	2.35e-06	8.52e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—HRAS—melanoma	2.31e-06	8.38e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—HRAS—melanoma	2.3e-06	8.36e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—HRAS—melanoma	2.3e-06	8.34e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—HRAS—melanoma	2.29e-06	8.31e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—AKT1—melanoma	2.28e-06	8.29e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—PIK3CA—melanoma	2.27e-06	8.24e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—HRAS—melanoma	2.27e-06	8.23e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—HRAS—melanoma	2.26e-06	8.21e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—AKT1—melanoma	2.25e-06	8.16e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—IL6—melanoma	2.24e-06	8.15e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—AKT1—melanoma	2.22e-06	8.05e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—IL6—melanoma	2.21e-06	8.02e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—IL6—melanoma	2.2e-06	8.01e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—IL6—melanoma	2.2e-06	7.98e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—TP53—melanoma	2.2e-06	7.97e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—IL6—melanoma	2.19e-06	7.95e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PIK3CD—melanoma	2.18e-06	7.9e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—IL6—melanoma	2.17e-06	7.88e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—IL6—melanoma	2.16e-06	7.86e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—ALB—melanoma	2.15e-06	7.8e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—HRAS—melanoma	2.1e-06	7.63e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—AKT1—melanoma	2.07e-06	7.52e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—AKT1—melanoma	2.04e-06	7.4e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—AKT1—melanoma	2.03e-06	7.39e-06	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—AKT1—melanoma	2.03e-06	7.38e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—AKT1—melanoma	2.03e-06	7.36e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—AKT1—melanoma	2.02e-06	7.34e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—IL6—melanoma	2.01e-06	7.3e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—AKT1—melanoma	2e-06	7.27e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—AKT1—melanoma	2e-06	7.25e-06	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PIK3CA—melanoma	1.92e-06	6.98e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PIK3CB—melanoma	1.9e-06	6.89e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PTGS2—melanoma	1.88e-06	6.83e-06	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PIK3CA—melanoma	1.88e-06	6.82e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—AKT1—melanoma	1.85e-06	6.73e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PIK3CA—melanoma	1.77e-06	6.42e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PTEN—melanoma	1.64e-06	5.95e-06	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—AKT1—melanoma	1.57e-06	5.71e-06	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—AKT1—melanoma	1.53e-06	5.57e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—AKT1—melanoma	1.44e-06	5.25e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PIK3CA—melanoma	1.16e-06	4.2e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—AKT1—melanoma	9.45e-07	3.43e-06	CbGpPWpGaD
